Literature DB >> 20406771

Arterial stiffness in chronic kidney disease: causes and consequences.

Colin D Chue1, Jonathan N Townend, Richard P Steeds, Charles J Ferro.   

Abstract

Chronic kidney disease is associated with elevated cardiovascular risk, and heart failure and arrhythmias are the biggest causes of cardiovascular death in this population. Increased arterial stiffness is a hallmark of chronic kidney disease and is associated with adverse alterations in cardiac structure and function that may predispose to an increased risk of cardiovascular death. These changes are already apparent in early kidney disease, which is highly prevalent in the developed world. The mechanisms underlying increased arterial stiffness in chronic kidney disease are undoubtedly complex, but an understanding is paramount to enable the development of novel therapeutic strategies to prevent or reverse this pathophysiology and therefore reduce the cardiovascular disease burden in this high-risk cohort.

Entities:  

Mesh:

Year:  2010        PMID: 20406771     DOI: 10.1136/hrt.2009.184879

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  56 in total

1.  The association between arterial stiffness and fluid status in peritoneal dialysis patients.

Authors:  Ismail Kocyigit; Murat Hayri Sipahioglu; Ozcan Orscelik; Aydin Unal; Ahmet Celik; Samer R Abbas; Fansan Zhu; Bulent Tokgoz; Ali Dogan; Oktay Oymak; Peter Kotanko; Nathan W Levin
Journal:  Perit Dial Int       Date:  2014-01-02       Impact factor: 1.756

2.  Association of H. pylori infection with chronic kidney disease among Chinese adults.

Authors:  Xianglei Kong; Dayu Xu; Feng Li; Xiaojing Ma; Hong Su; Dongmei Xu
Journal:  Int Urol Nephrol       Date:  2017-01-02       Impact factor: 2.370

Review 3.  Arterial stiffness, vascular calcification and bone metabolism in chronic kidney disease.

Authors:  János Nemcsik; István Kiss; András Tislér
Journal:  World J Nephrol       Date:  2012-02-06

4.  Chronic kidney disease: Arterial stiffness and renal function--a complex relationship.

Authors:  Paolo Salvi; Gianfranco Parati
Journal:  Nat Rev Nephrol       Date:  2014-12-09       Impact factor: 28.314

5.  Vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease.

Authors:  Kristen L Nowak; Heather Farmer; Melissa A Cadnapaphornchai; Berenice Gitomer; Michel Chonchol
Journal:  Nephrol Dial Transplant       Date:  2017-02-01       Impact factor: 5.992

Review 6.  Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction.

Authors:  Tatjana S Potpara; Charles J Ferro; Gregory Y H Lip
Journal:  Nat Rev Nephrol       Date:  2018-03-26       Impact factor: 28.314

7.  Assessment of vascular function in patients with chronic kidney disease.

Authors:  Kristen L Jablonski; Emily Decker; Loni Perrenoud; Jessica Kendrick; Michel Chonchol; Douglas R Seals; Diana Jalal
Journal:  J Vis Exp       Date:  2014-06-16       Impact factor: 1.355

8.  Cardiovascular effects of sevelamer in stage 3 CKD.

Authors:  Colin D Chue; Jonathan N Townend; William E Moody; Daniel Zehnder; Nadezhda A Wall; Lorraine Harper; Nicola C Edwards; Richard P Steeds; Charles J Ferro
Journal:  J Am Soc Nephrol       Date:  2013-04-18       Impact factor: 10.121

9.  Hyperhomocysteinemia increases the risk of chronic kidney disease in a Chinese middle-aged and elderly population-based cohort.

Authors:  Xianglei Kong; Xiaojing Ma; Chengyin Zhang; Hong Su; Dongmei Xu
Journal:  Int Urol Nephrol       Date:  2016-11-07       Impact factor: 2.370

10.  FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability.

Authors:  Neerupma Silswal; Chad D Touchberry; Dorothy R Daniel; Darla L McCarthy; Shiqin Zhang; Jon Andresen; Jason R Stubbs; Michael J Wacker
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-07-22       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.